Glen Santangelo
Stock Analyst at Barclays
(2.32)
# 2,727
Out of 5,182 analysts
139
Total ratings
44.21%
Success rate
-1.19%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTEV Claritev | Initiates: Overweight | $28 | $23.49 | +19.20% | 1 | Apr 24, 2026 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Equal-Weight | $30 → $23 | $21.82 | +5.41% | 4 | Apr 8, 2026 | |
| PHAT Phathom Pharmaceuticals | Upgrades: Overweight | $16 → $18 | $11.33 | +58.87% | 3 | Mar 27, 2026 | |
| TDOC Teladoc Health | Maintains: Equal-Weight | $8.5 → $7 | $6.00 | +16.67% | 9 | Mar 26, 2026 | |
| PCRX Pacira BioSciences | Maintains: Equal-Weight | $27 → $25 | $25.41 | -1.61% | 7 | Mar 26, 2026 | |
| VTRS Viatris | Maintains: Overweight | $15 → $17 | $14.82 | +14.71% | 6 | Mar 24, 2026 | |
| ALVO Alvotech | Maintains: Underweight | $5 → $4 | $3.52 | +13.64% | 2 | Mar 24, 2026 | |
| PGNY Progyny | Maintains: Overweight | $29 → $23 | $18.38 | +25.14% | 6 | Mar 20, 2026 | |
| ALGN Align Technology | Upgrades: Overweight | $200 | $177.28 | +12.82% | 4 | Mar 17, 2026 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $25 → $29 | $27.91 | +3.91% | 7 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $5.5 → $5.25 | $5.19 | +1.16% | 3 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $7 | $5.67 | +23.46% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $7.5 → $8 | $13.32 | -39.94% | 2 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $243 → $258 | $205.61 | +25.48% | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $960 → $1,050 | $835.00 | +25.75% | 7 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $118 → $110 | $81.18 | +35.50% | 8 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $425 | $311.99 | +36.22% | 2 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $34 | $26.49 | +28.35% | 3 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $63 → $38 | $24.57 | +54.66% | 4 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $850 → $800 | $568.30 | +40.77% | 2 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $38 | $31.62 | +20.18% | 7 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $5.25 → $2.75 | $2.32 | +18.53% | 3 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $44.24 | +13.02% | 1 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $56 | $32.81 | +70.68% | 5 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $24 | $9.42 | +154.78% | 3 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $136 | $116.65 | +16.59% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $6.09 | +47.78% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $62.09 | +61.06% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $86 | $76.12 | +12.98% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $22.15 | +35.44% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $12 | $11.78 | +1.87% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $78.50 | +27.39% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $12.74 | +17.79% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $34.81 | +40.76% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $25.23 | +102.14% | 1 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $6.53 | +1,431.39% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $70.92 | -22.44% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $75 | $9.60 | +681.25% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $1.34 | +1,997.38% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $6.25 | +1,820.00% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $1.01 | +3,464.36% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $80.98 | - | 3 | Mar 17, 2021 |
Claritev
Apr 24, 2026
Initiates: Overweight
Price Target: $28
Current: $23.49
Upside: +19.20%
Amphastar Pharmaceuticals
Apr 8, 2026
Maintains: Equal-Weight
Price Target: $30 → $23
Current: $21.82
Upside: +5.41%
Phathom Pharmaceuticals
Mar 27, 2026
Upgrades: Overweight
Price Target: $16 → $18
Current: $11.33
Upside: +58.87%
Teladoc Health
Mar 26, 2026
Maintains: Equal-Weight
Price Target: $8.5 → $7
Current: $6.00
Upside: +16.67%
Pacira BioSciences
Mar 26, 2026
Maintains: Equal-Weight
Price Target: $27 → $25
Current: $25.41
Upside: -1.61%
Viatris
Mar 24, 2026
Maintains: Overweight
Price Target: $15 → $17
Current: $14.82
Upside: +14.71%
Alvotech
Mar 24, 2026
Maintains: Underweight
Price Target: $5 → $4
Current: $3.52
Upside: +13.64%
Progyny
Mar 20, 2026
Maintains: Overweight
Price Target: $29 → $23
Current: $18.38
Upside: +25.14%
Align Technology
Mar 17, 2026
Upgrades: Overweight
Price Target: $200
Current: $177.28
Upside: +12.82%
Hims & Hers Health
Mar 11, 2026
Maintains: Overweight
Price Target: $25 → $29
Current: $27.91
Upside: +3.91%
Mar 10, 2026
Maintains: Equal-Weight
Price Target: $5.5 → $5.25
Current: $5.19
Upside: +1.16%
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $8 → $7
Current: $5.67
Upside: +23.46%
Feb 24, 2026
Maintains: Underweight
Price Target: $7.5 → $8
Current: $13.32
Upside: -39.94%
Feb 24, 2026
Maintains: Overweight
Price Target: $243 → $258
Current: $205.61
Upside: +25.48%
Feb 18, 2026
Maintains: Overweight
Price Target: $960 → $1,050
Current: $835.00
Upside: +25.75%
Feb 18, 2026
Maintains: Overweight
Price Target: $118 → $110
Current: $81.18
Upside: +35.50%
Feb 13, 2026
Maintains: Overweight
Price Target: $400 → $425
Current: $311.99
Upside: +36.22%
Feb 11, 2026
Maintains: Overweight
Price Target: $24 → $34
Current: $26.49
Upside: +28.35%
Feb 11, 2026
Maintains: Overweight
Price Target: $63 → $38
Current: $24.57
Upside: +54.66%
Feb 5, 2026
Maintains: Overweight
Price Target: $850 → $800
Current: $568.30
Upside: +40.77%
Jan 30, 2026
Maintains: Overweight
Price Target: $35 → $38
Current: $31.62
Upside: +20.18%
Jan 22, 2026
Downgrades: Hold
Price Target: $5.25 → $2.75
Current: $2.32
Upside: +18.53%
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $44.24
Upside: +13.02%
Jan 9, 2026
Maintains: Overweight
Price Target: $58 → $56
Current: $32.81
Upside: +70.68%
Dec 16, 2025
Maintains: Overweight
Price Target: $26 → $24
Current: $9.42
Upside: +154.78%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $136
Current: $116.65
Upside: +16.59%
Dec 9, 2025
Initiates: Overweight
Price Target: $9
Current: $6.09
Upside: +47.78%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $62.09
Upside: +61.06%
Dec 9, 2025
Initiates: Overweight
Price Target: $86
Current: $76.12
Upside: +12.98%
Dec 9, 2025
Initiates: Overweight
Price Target: $30
Current: $22.15
Upside: +35.44%
Dec 9, 2025
Initiates: Underweight
Price Target: $12
Current: $11.78
Upside: +1.87%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $78.50
Upside: +27.39%
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $12.74
Upside: +17.79%
Dec 9, 2025
Initiates: Overweight
Price Target: $49
Current: $34.81
Upside: +40.76%
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $25.23
Upside: +102.14%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $6.53
Upside: +1,431.39%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $70.92
Upside: -22.44%
Oct 21, 2022
Assumes: Buy
Price Target: $75
Current: $9.60
Upside: +681.25%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $1.34
Upside: +1,997.38%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $6.25
Upside: +1,820.00%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $1.01
Upside: +3,464.36%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $80.98
Upside: -